Leptin receptor blockade reduces intrahepatic vascular resistance and portal pressure in an experimental model of rat liver cirrhosis

Functional aspects on the pathophysiology of portal hypertension in cirrhosis

(2012) Juan-Carlos García-Pagán et al.   JOURNAL OF HEPATOLOGY

Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats

(2012) Maeva Guillaume et al.   JOURNAL OF HEPATOLOGY

Endothelial dysfunction in the regulation of cirrhosis and portal hypertension

(2011) Yasuko Iwakiri   LIVER INTERNATIONAL

Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver

(2010) J. Gracia-Sancho et al.   GUT

Hepatic endothelial dysfunction and abnormal angiogenesis: New targets in the treatment of portal hypertension

(2010) Jaume Bosch et al.   JOURNAL OF HEPATOLOGY

Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats

(2010) Héctor García-Calderó et al.   JOURNAL OF HEPATOLOGY

Angiogenesis in liver disease

(2009) Mercedes Fernández et al.   JOURNAL OF HEPATOLOGY

Leptin-induced endothelial dysfunction in obesity

(2008) Mykhaylo Korda et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

A neutralizing leptin receptor antibody mitigates hypertrophy and hemodynamic dysfunction in the postinfarcted rat heart

(2008) Daniel M. Purdham et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Identification of Leptin Gene Expression in Sinusoidal Endothelial Rat Liver Cells

(2008) Miguel R. Reyes et al.   ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH

Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension

(2008) B Lavina et al.   GUT

Competitive inhibition of leptin signaling results in amelioration of liver fibrosis through modulation of stellate cell function

(2008) Eran Elinav et al.   HEPATOLOGY

Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats

(2008) Vasilica Matei et al.   JOURNAL OF HEPATOLOGY

Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease

(2008) Xiao-Dong Huang et al.   WORLD JOURNAL OF GASTROENTEROLOGY